Physician

Albert C Lin, M.D.

According to 2025 Medicare claims, Albert Lin, M.D. (NPI: 1508820218) practices cardiac electrophysiology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is NORTHWESTERN MEDICAL FACULTY FOUNDATION (NPI: 1346235314; TIN: 363097297) and primary practice location at 60611-2908. Lin is affiliated with the Northwestern Medicine Physician Network ACO (ACO ID: A2620) and Northwestern Medicine Health Network ACO LLC (ACO ID: A5444), participating under the MSSP model.

Lin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 735 traditional Medicare patients, billed 2,333 HCPCS/CPT codes, and received $177,013 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 824 prescription claims across 237 beneficiaries totaling $491,094 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 60 records totaling $22,958. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $92,130 to $491,094. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	818	1,576	$147,572
2016	541	1,297	$131,014
2017	703	1,840	$150,168
2018	805	2,183	$176,601
2019	1,287	3,075	$201,775
2020	938	2,678	$162,660
2021	1,057	2,858	$213,488
2022	863	2,587	$194,528
2023	1,026	2,870	$185,572
2024	735	2,333	$177,013

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	82	375	$92,130
2016	102	455	$87,247
2017	135	648	$145,311
2018	158	773	$216,087
2019	182	892	$287,486
2020	165	806	$277,980
2021	203	780	$316,285
2022	225	898	$433,201
2023	243	844	$500,206
2024	237	824	$491,094

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	99	111	$76
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	136	370	$22
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	211	553	$15
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	90	109	$12
93246	Heart rhythm recording of continous external ekg over 8-15 days	106	107	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	239	17,594	$336,712
Xarelto	Rivaroxaban	66	4,307	$78,385
Multaq	Dronedarone Hcl	30	1,860	$47,552
Dofetilide	Dofetilide	23	1,980	$11,909
Metoprolol Succinate	Metoprolol Succinate	182	15,644	$3,370

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	50	$7,403	Cook Incorporated
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$15,555	Boston Scientific Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Albert C. Lin, M.D.?

Tedicare shows public-source Medicare data for Albert C. Lin, M.D. (NPI 1508820218), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Albert C. Lin, M.D. have ACO affiliation data?

Albert C. Lin, M.D. is shown with ACO affiliation data for Northwestern Medicine Physician Network ACO (MSSP, ACO ID A2620) and Northwestern Medicine Health Network ACO LLC (MSSP, ACO ID A5444).

What billing organization is linked to Albert C. Lin, M.D.?

Albert C. Lin, M.D. is linked to NORTHWESTERN MEDICAL FACULTY FOUNDATION (billing NPI 1346235314) in the available physician profile data.

Does Albert C. Lin, M.D. have Open Payments data?

Albert C. Lin, M.D. has 60 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.